The Pros and Cons of Disease Modifying Therapies in Alzheimer’s Disease – Fully Understanding Counterbalancing Benefits, Burdens, Risks, and Costs. Nov 10 Written by Canadian Geriatric Society Click Here to Read disease modifying therapyalzheimer's diseaseDementia Preventionanti-amyloid antibodieslecanemabdonanemab Canadian Geriatric Society Next Next Management of Wandering in Older Adults with Dementia in the Community and Long-Term Care
The Pros and Cons of Disease Modifying Therapies in Alzheimer’s Disease – Fully Understanding Counterbalancing Benefits, Burdens, Risks, and Costs. Nov 10 Written by Canadian Geriatric Society Click Here to Read disease modifying therapyalzheimer's diseaseDementia Preventionanti-amyloid antibodieslecanemabdonanemab Canadian Geriatric Society
